| Year |
Citation |
Score |
| 2020 |
Chau JJ, Yadav M, Furqan M, Mercer K, Eastman E, Shahi S, Dai Q, Chan C, Weiner G, Hejleh TA, Mangalam A, Zhang J. Abstract B24: The microbiome in lung cancer under immunotherapy: Significant compositional differences associated with treatment response and AEs Cancer Research. 80. DOI: 10.1158/1538-7445.Mvc2020-B24 |
0.312 |
|
| 2017 |
Zhang J, Nannapaneni S, Wang D, Liu F, Wang X, Jin R, Liu X, Rahman MA, Peng X, Qian G, Chen ZG, Wong KK, Khuri FR, Zhou W, Shin DM. Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status. Oncotarget. 8: 59008-59022. PMID 28938614 DOI: 10.18632/Oncotarget.19779 |
0.319 |
|
| 2017 |
Li R, Ding C, Zhang J, Xie M, Park D, Ding Y, Chen G, Zhang G, Gilbert-Ross M, Zhou W, Marcus A, Sun SY, Chen ZG, Sica GL, Ramalingam SS, et al. Modulation of Bax and mTOR for cancer therapeutics. Cancer Research. PMID 28381544 DOI: 10.1158/0008-5472.Can-16-2356 |
0.305 |
|
| 2017 |
Li R, Ding C, Zhang J, Xie M, Park D, Ding Y, Chen G, Zhang G, Gilbert-Ross M, Zhou W, Marcus A, Sun S, Chen Z, Sica G, Ramalingam S, et al. Abstract 2333: Modulation of Bax and mTOR for cancer therapeutics Cancer Research. 77: 2333-2333. DOI: 10.1158/1538-7445.Am2017-2333 |
0.33 |
|
| 2016 |
Wang Y, Liu Y, Zhao C, Li X, Wu C, Hou L, Zhang S, Jiang T, Chen X, Su C, Gao G, Li W, Wu F, Li A, Ren S, ... ... Zhang J, et al. Feasibility of cytological specimens for ALK fusion detection in patients with advanced NSCLC using the method of RT-PCR. Lung Cancer (Amsterdam, Netherlands). 94: 28-34. PMID 26973203 DOI: 10.1016/J.Lungcan.2016.01.014 |
0.304 |
|
| 2015 |
Zhang J, Park D, Shin DM, Deng X. Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities. Acta Biochimica Et Biophysica Sinica. PMID 26578706 DOI: 10.1093/Abbs/Gmv118 |
0.33 |
|
| 2015 |
Wu C, Zhao C, Yang Y, He Y, Hou L, Li X, Gao G, Shi J, Ren S, Chu H, Zhou C, Zhang J, Schmid-Bindert G. High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 778-83. PMID 25629635 DOI: 10.1097/Jto.0000000000000487 |
0.301 |
|
| 2015 |
Wang X, Beitler JJ, Huang W, Qian G, Magliocca K, Zhang J, Nannapaneni S, Kim S, Chen Z, Nabil SF, Chen ZG, Arbiser JL, Shin DM. Abstract 20: Honokiol radiosensitizes squamous cells carcinoma of head and neck by down-regulation of survivin Cancer Research. 75: 20-20. DOI: 10.1158/1538-7445.Am2015-20 |
0.302 |
|
| 2015 |
Rahman MA, Amin ARMR, Zhang J, Nannapaneni S, Saba NF, Chen ZG, Shin DM. Abstract 1428: Targeting RRM2 by siRNA inhibits cellular invasion and represents a rational approach for inhibition of metastasis of head and neck and lung cancers Cancer Research. 75: 1428-1428. DOI: 10.1158/1538-7445.Am2015-1428 |
0.326 |
|
| 2014 |
Zhou W, Zhang J, Marcus AI. LKB1 Tumor Suppressor: Therapeutic Opportunities Knock when LKB1 Is Inactivated. Genes & Diseases. 1: 64-74. PMID 25679014 DOI: 10.1016/J.Gendis.2014.06.002 |
0.317 |
|
| 2014 |
Zhang J, Wang D, Qian G, Liu F, Rahman MA, Nannapaneni S, Wang X, Peng X, Chen ZG, Wong K, Khuri FR, Zhou W, Shin DM. Phenformin combines with selumetinib in targeting KRAS mutant non-small cell lung cancer cells with alternative LKB1 status. Journal of Clinical Oncology. 32: 2589-2589. DOI: 10.1200/Jco.2014.32.15_Suppl.2589 |
0.324 |
|
| Show low-probability matches. |